HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aripiprazole prevents renal ischemia/reperfusion injury in rats, probably through nitric oxide involvement.

Abstract
Renal ischemia/reperfusion (I/R) injury is strongly related to morbidity and mortality. Oxidative stress, inflammation, and apoptosis play key roles in renal dysfunction following renal I/R. Aripiprazole is an atypical antipsychotic which used for the treatment of schizophrenia and bipolar disorder. Recent studies have reported aripiprazole as displaying certain anti-inflammatory effects. Regarding the underlying mechanisms of renal ischemia-reperfusion, therefore, nephroprotective effects might be predicted to be seen with aripiprazole. I/R injury was induced by bilateral clamping of the renal pedicles (45min) followed by reperfusion (24h). The mechanism of aripiprazole-mediated nephroprotection was explored by a combined use of aripiprazole and L-NAME (non-selective nitric oxide synthase inhibitor). Animals were given aripiprazole (2.5, 5, 10 and 20mg/kg) intraperitoneally, 30min before ischemia. L-NAME was administered before the aripiprazole injection. Serum creatinine and blood urea nitrogen were assessed after 24h of reperfusion. Serum levels of malondialdehyde (MDA), TNF-α and IL-1β were measured for rats treated with aripiprazole. The extent of necrosis was measured by the stereology method. Ischemia/reperfusion caused significant renal dysfunction and marked renal injury. Aripiprazole reduced creatinine and blood urea nitrogen. Serum levels of MDA, IL-1β and TNF-α were significantly lower in the aripiprazole group. Aripiprazole treatment also decreased the volume of kidney necrosis. The administration of L-NAME reversed the renoprotective effect of aripiprazole on BUN and creatinine, but enhanced the anti-necrotic effect of aripiprazole. The results show that a single dose of aripiprazole significantly improved renal function following ischemia/reperfusion injury - probably through the involvement of nitric oxide.
AuthorsHanieh Gholampour, Leila Moezi, Hamed Shafaroodi
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 813 Pg. 17-23 (Oct 15 2017) ISSN: 1879-0712 [Electronic] Netherlands
PMID28734929 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier B.V. All rights reserved.
Chemical References
  • Interleukin-1beta
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • Aripiprazole
  • Creatinine
  • NG-Nitroarginine Methyl Ester
Topics
  • Animals
  • Aripiprazole (pharmacology)
  • Blood Urea Nitrogen
  • Creatinine (blood)
  • Cytoprotection (drug effects)
  • Interleukin-1beta (blood)
  • Kidney (drug effects, metabolism, pathology, physiopathology)
  • Male
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Necrosis
  • Nitric Oxide (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (metabolism, pathology, physiopathology, prevention & control)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: